Individualised dosing of anti-thymocyte globulin in paediatric unrelated allogeneic haematopoietic stem-cell transplantation (PARACHUTE): a single-arm, phase 2 clinical trial
Rick Admiraal(NHS Blood and Transplant), Jaap Jan Boelens(Wilhelmina Children's Hospital), C. Michel Zwaan(Hôpital Saint-Michel), Robbert G. M. Bredius(Leiden University Medical Center), Ineke van Vliet, Caroline A. Lindemans(University Medical Center Utrecht), Marc Bierings(University Medical Center Utrecht), A. Birgitta Versluijs(NHS Blood and Transplant), Marta López‐Yurda(The Netherlands Cancer Institute), Stefan Nierkens(Utrecht University), Yilin Jiang(Princess Máxima Center)
Cited by 71
Related Papers
Gut microbiome–derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease
|Nature Immunology|2016|727
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
|Blood|2016|554
Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL
|Nature Genetics|2007|387